Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval
September 13, 2023 03:00 ET
|
Rentschler Biopharma SE
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapyHighly experienced team ready to support ATMP innovators at all stagesOffering comprehensive range of...
Rentschler Biopharma Receives Worcester Business Journal 2023 Manufacturing Excellence Award
April 27, 2023 10:00 ET
|
Rentschler Biopharma SE
Company presented with Workforce Development Award, recognizing partnership with MassBioEd and WPI to train people for biotech manufacturing positions Company honored at Worcester Business Journal...
Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific Officer, strengthening scientific focus
September 20, 2021 07:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...